论文部分内容阅读
哈励逊国际和平医院王建修以末稍血中性白细胞核突率(简称EWBCMT)诊断恶性肿瘤,已通过省级鉴定,并获科技进步奖。王建修等对500例分组进行了观察(健康人组150例;各种慢性病组,包括良性肿瘤病例计150例;癌与肉瘤200例;恶性肿瘤术后组又多观察80例)。结果发现,恶性肿瘤组(术前)的白细胞核突率明显高于各对照组,两者之间有非常显著性差异(P<0.01)。而在恶性肿瘤组中,术前与术后白细胞核突的观察,术后组较术前组低,两组经统计学处理亦有显著差异(P<0.01)。
Harrison International Peace Hospital Wang Jianxiu diagnosed malignant tumors with a terminal blood neutrophil nuclear burst rate (EWBCMT). It has passed provincial appraisal and won the Science and Technology Progress Award. Wang Jianxiu et al. observed 500 subgroups (150 in the healthy group; 150 in various chronic diseases including benign tumors; 200 in carcinomas and sarcomas; 80 in malignant tumors after surgery). The results showed that the leukocyte nuclear burst rate in the malignant tumor group (preoperatively) was significantly higher than that of the control group, and there was a very significant difference between the two groups (P<0.01). In the malignant tumor group, the preoperative and postoperative leukocyte nuclear burst observations were lower in the postoperative group than in the preoperative group, and there was also a statistically significant difference between the two groups (P<0.01).